OTCPK:LKNC.Y
OTCPK:LKNC.YHospitality

Luckin’s Rapid Expansion And Premium Acquisition Talks Might Change The Case For Investing In LKNC.Y

In recent weeks, Luckin Coffee reported double-digit growth in store count, monthly active customers, same-store sales, and revenue, while also confirming it is in early-stage talks to acquire premium brands such as Nestlé’s Blue Bottle Coffee and the operator of % Arabica’s China business. This combination of rapid operational expansion and a potential move upmarket into premium coffee suggests Luckin is testing how far its model can stretch beyond low-priced, app-driven beverages. With...
NasdaqGS:MU
NasdaqGS:MUSemiconductor

Micron Technology (MU): Rethinking Valuation After a 64% Three-Month Surge in the Share Price

Micron Technology (MU) has quietly turned into one of the market’s stronger performers, with the stock up about 64% over the past 3 months and roughly doubling over the past year. See our latest analysis for Micron Technology. The latest leg higher, including a 6.99% 1 day share price return to around $265.92 and a 17.71% 1 month share price return, reinforces a powerful uptrend that mirrors Micron’s improving growth narrative and shifting market sentiment around memory demand. If Micron’s...
NYSE:LUMN
NYSE:LUMNTelecom

What Lumen Technologies (LUMN)'s Media Skepticism Amid Transformation Efforts Means For Shareholders

Earlier this week, investor caution around Lumen Technologies intensified after CNBC’s Jim Cramer argued the stock had “run too much,” even as the company pursued initiatives like a networking partnership with Meter and expanded cybersecurity capabilities in Asia-Pacific. The mixed message of media skepticism alongside new enterprise-focused offerings highlights the tension between Lumen’s transformation efforts and ongoing concerns over declining revenue and weakening free cash flow. Next,...
NYSE:ATO
NYSE:ATOGas Utilities

Is Atmos Energy Still Attractive After Its Strong Multi Year Share Price Surge in 2025?

If you are wondering whether Atmos Energy is still a smart buy after its long run up, or if you would be overpaying at today’s price, this article will walk through what the numbers are really saying about its valuation. Even after a small pullback of about 1.0% over the last week and 4.2% over the last month, the stock is still up roughly 20.5% year to date and 22.0% over the past year, building on strong multi year gains of 56.1% over three years and 103.8% over five. Recent price moves...
NasdaqGS:BIIB
NasdaqGS:BIIBBiotechs

RBC’s Confidence in Leqembi and MS Pipeline Might Change The Case For Investing In Biogen (BIIB)

Earlier this week, RBC Capital reaffirmed its positive view on Biogen, highlighting stabilization in the company’s core neurology franchise and growing expectations for Alzheimer’s therapy Leqembi, alongside the upcoming clinical trial start for multiple sclerosis candidate BIIB145. The endorsement underscores how Biogen’s deep experience in neurological diseases may help it convert emerging Alzheimer’s demand and new MS research into a more resilient business mix over time. We’ll now...
NasdaqGS:WAY
NasdaqGS:WAYHealthcare Services

Waystar (WAY): Assessing Valuation After UBS Initiates Coverage With a Buy Rating

Waystar Holding (WAY) just picked up fresh attention after UBS initiated coverage with a buy rating, putting the healthcare payments software provider back on the radar for growth focused investors. See our latest analysis for Waystar Holding. With the share price around $32.84, Waystar’s short term share price returns have been choppy, and its 1 year total shareholder return of about negative 11 percent suggests momentum has been fading despite solid underlying growth. If this UBS call has...